Stocktoria

Tempest Therapeutics, Inc. TPST

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-10-04

Tempest Therapeutics, Inc. insider transactions (Form 4)

InsiderRoleDateActionSharesPrice
Angel MatthewCEO and President2026-03-24Buy231,482$2.16
Angel MatthewCEO and President2026-03-24Buy231,482$2.16

Source: SEC EDGAR filings · CIK 0001544227 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.